| Product Code: ETC9409014 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Neuropathic Pain Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Neuropathic Pain Market - Industry Life Cycle |
3.4 South Korea Neuropathic Pain Market - Porter's Five Forces |
3.5 South Korea Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 South Korea Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 South Korea Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 South Korea Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 South Korea Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 South Korea Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 South Korea Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases leading to neuropathic pain |
4.2.2 Growing awareness and diagnosis of neuropathic pain in South Korea |
4.2.3 Advancements in healthcare infrastructure and technology for neuropathic pain treatment |
4.3 Market Restraints |
4.3.1 High cost associated with neuropathic pain medications and treatments |
4.3.2 Limited access to specialized healthcare providers for neuropathic pain management |
4.3.3 Regulatory challenges in the approval process for new neuropathic pain therapies |
5 South Korea Neuropathic Pain Market Trends |
6 South Korea Neuropathic Pain Market, By Types |
6.1 South Korea Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 South Korea Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 South Korea Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 South Korea Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 South Korea Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 South Korea Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 South Korea Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 South Korea Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 South Korea Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 South Korea Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 South Korea Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 South Korea Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 South Korea Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 South Korea Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 South Korea Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 South Korea Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 South Korea Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 South Korea Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 South Korea Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 South Korea Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 South Korea Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 South Korea Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 South Korea Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 South Korea Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 South Korea Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 South Korea Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 South Korea Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 South Korea Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 South Korea Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 South Korea Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Neuropathic Pain Market Import-Export Trade Statistics |
7.1 South Korea Neuropathic Pain Market Export to Major Countries |
7.2 South Korea Neuropathic Pain Market Imports from Major Countries |
8 South Korea Neuropathic Pain Market Key Performance Indicators |
8.1 Average wait time for neuropathic pain treatment appointments |
8.2 Percentage of patients reporting improved pain management after treatment |
8.3 Number of research studies and clinical trials focused on neuropathic pain therapies |
8.4 Patient satisfaction scores with neuropathic pain treatment options |
8.5 Adoption rate of non-pharmacological interventions for neuropathic pain relief |
9 South Korea Neuropathic Pain Market - Opportunity Assessment |
9.1 South Korea Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 South Korea Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 South Korea Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 South Korea Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 South Korea Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 South Korea Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 South Korea Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 South Korea Neuropathic Pain Market - Competitive Landscape |
10.1 South Korea Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 South Korea Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here